Healthcare Medical Devices Biotechnology

Bioanalytical Testing Services Market

Global Industry Analysis and Forecast 2024-2031

Pages : 120

Base Year : 2023

Release Year : May 2024

Format : Pdf Ppt Xls

Report ID: KR589

Author : Omkar R.

Base Year

2023

Forecast Year

2024-2031

Historical Years

2019-2022

Market Value (2023)

USD 4.71 Billion

Forecasted Value (2031)

USD 9.74 Billion

CAGR (2024 - 2031)

9.53%

Fastest Growing Region (2024 - 2031)

Asia Pacific

Largest Region

North America

By Service

Small Molecular Bioanalysis, Large Molecular Bioanalysis

By Test Type

Bioavailability, Bioequivalence, Pharmacokinetics, Pharmacodynamics, Others

By Application

Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, Other Applications


infographics Img
CHOOSE LICENCE TYPE
CUSTOMIZATION OFFERED
  • Check Icon Additional Company Profiles
  • Check Icon Additional Countries
  • Check Icon Cross Segment Analysis
  • Check Icon Regional Market Dynamics
  • Check Icon Country-Level Trend Analysis
  • Check Icon Competitive Landscape Customization
  • Check Icon Extended Forecast Years
  • Check Icon Historical Data Up to 5 Years
The global bioanalytical testing services market is projected to reach USD 9.74 billion by 2031, growing at a CAGR of 9.53% from 2024 to 2031.
The global bioanalytical testing services market was valued at USD 4.71 billion in 2023.
The increasing prevalence of chronic diseases and the growing adoption of personalized medicine are driving demand for bioanalytical testing services worldwide.
Top manufacturers of bioanalytical testing services market are Charles River Laboratories International, Inc., Eurofins Scientific SE, Laboratory Corporation of America Holdings (LabCorp), Pharmaceutical Product Development, LLC (PPD), ICON plc, SGS SA, WuXi AppTec, BioAgilytix Labs, Intertek Group plc, PRA Health Sciences, Inc., and others.
Asia-Pacific is the fastest growing region with the CAGR of 10.50% in the forecasted period (2024-2031) with the market value forecasted to reach at USD 2.71 billion.
By test type, bioavailability will hold the maximum share in the bioanalytical testing services market with the revenue value of USD 3.36 billion in 2031.
-->
Get the latest!

Get actionable strategies to empower your business and market domination

  • Deliver Revenue Impact
  • Demand Supply Patterns
  • Market Estimation
  • Real-Time Insights
  • Market Intelligence
  • Lucrative Growth Opportunities
  • Micro & Macro Economic Factors
  • Futuristic Market Solutions
  • Revenue-Driven Results
  • Innovative Thought Leadership